{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:49:42Z","timestamp":1793692182628,"version":"4.5.1"},"reference-count":484,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005187","name":"National and Kapodistrian University of Athens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pharmr.2026.100118","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:26:07Z","timestamp":1768609567000},"page":"100118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacological modulation of the blood-brain barrier: Mechanisms, therapeutic strategies, and emerging technologies"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6684-356X","authenticated-orcid":false,"given":"Iosif","family":"Pediaditakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7564-6724","authenticated-orcid":false,"given":"Serena","family":"Tsakali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5875-9579","authenticated-orcid":false,"given":"Maddie R.","family":"Lemieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3327-0352","authenticated-orcid":false,"given":"Spyridon","family":"Papapetropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-5930","authenticated-orcid":false,"given":"Andreas","family":"Papapetropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13195-024-01529-1","article-title":"Assessing blood-brain barrier dysfunction and its association with Alzheimer\u2019s pathology, cognitive impairment and neuroinflammation","volume":"16","author":"Preis","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100118_bib3","doi-asserted-by":"crossref","first-page":"R1010","DOI":"10.1016\/j.cub.2025.06.061","article-title":"The blood-brain barrier","volume":"35","author":"Chagnot","year":"2025","journal-title":"Curr Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/cells13020150","article-title":"Involvement of astrocytes in the formation, maintenance, and function of the blood\u2013brain barrier","volume":"13","author":"Schiera","year":"2024","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100118_bib6","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/glia.20990","article-title":"The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction","volume":"58","author":"Mathiisen","year":"2010","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/cells11050813","article-title":"Metabolic contribution and cerebral blood flow regulation by astrocytes in the neurovascular unit","volume":"11","author":"Takahashi","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1143544","article-title":"Heterogeneity of the blood-brain barrier","volume":"4","author":"Wilhelm","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.pharmr.2026.100118_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.696540","article-title":"Location matters: navigating regional heterogeneity of the neurovascular unit","volume":"15","author":"Bernier","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100118_bib11","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/s41593-024-01743-y","article-title":"Characteristics of blood\u2013brain barrier heterogeneity between brain regions revealed by profiling vascular and perivascular cells","volume":"27","author":"Pfau","year":"2024","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00018-015-2050-8","article-title":"Factors controlling permeability of the blood\u2013brain barrier","volume":"73","author":"Almutairi","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100118_bib13","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1111\/febs.13412","article-title":"The dynamic blood-brain barrier","volume":"282","author":"Keaney","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.pharmr.2026.100118_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer\u2019s disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pharmr.2026.100118_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1258640","article-title":"Blood-brain barrier dysfunction and Alzheimer\u2019s disease: associations, pathogenic mechanisms, and therapeutic potential","volume":"15","author":"Chen","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.pharmr.2026.100118_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib18","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1038\/s41467-021-26066-5","article-title":"Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption","volume":"12","author":"Pediaditakis","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0271678X231153281","article-title":"Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: proposed mechanisms and clinical implications","volume":"43","author":"Steinruecke","year":"2023","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood\u2013brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy","volume":"13","author":"Lau","year":"2024","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","article-title":"Blood\u2013brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies","volume":"23","author":"Zierfuss","year":"2024","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100118_bib22","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s10571-018-0609-2","article-title":"Mechanisms of blood brain barrier disruption by different types of bacteria, and bacterial-host interactions facilitate the bacterial pathogen invading the brain","volume":"38","author":"Al-Obaidi","year":"2018","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib23","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3390\/ijms24032852","article-title":"Blood-brain barrier integrity damage in bacterial meningitis: the underlying link, mechanisms, and therapeutic targets","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"Neurorx"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2026.100118_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165\u2013166","author":"Pandit","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","author":"Steinmetz","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharmr.2026.100118_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108985","article-title":"In vivo imaging of alpha-synuclein with antibody-based PET","volume":"208","author":"Roshanbin","year":"2022","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12987-022-00398-w","article-title":"Brain pharmacokinetics of mono- and bispecific amyloid-\u03b2 antibodies in wild-type and Alzheimer\u2019s disease mice measured by high cut-off microdialysis","volume":"19","author":"Julku","year":"2022","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14283\/jpad.2023.6","article-title":"Investigating partially discordant results in phase 3 studies of aducanumab","volume":"10","author":"Mallinckrodt","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized Phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12987-024-00563-3","article-title":"Blood-brain barrier disruption: a culprit of cognitive decline?","volume":"21","author":"Che","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib33","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190062","article-title":"The blood\u2013brain barrier in health and disease: important unanswered questions","volume":"217","author":"Profaci","year":"2020","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100118_bib34","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00018-019-03030-7","article-title":"Tight junction proteins at the blood\u2013brain barrier: far more than claudin-5","volume":"76","author":"Berndt","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.201412147","article-title":"Brain barriers: crosstalk between complex tight junctions and adherens junctions","volume":"209","author":"Tietz","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmr.2026.100118_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63253","article-title":"Nano-scale architecture of blood-brain barrier tight-junctions","volume":"10","author":"Sasson","year":"2021","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib37","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2024.2330773","article-title":"Inter-claudin antagonism of paracellular pore function: mechanism and beyond","volume":"13","author":"Wachiradejkul","year":"2024","journal-title":"Tissue Barriers"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0271678X15617954","article-title":"Neurovascular coupling in humans: physiology, methodological advances and clinical implications","volume":"36","author":"Phillips","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100118_bib39","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1016\/j.cell.2025.06.030","article-title":"Brain endothelial gap junction coupling enables rapid vasodilation propagation during neurovascular coupling","volume":"188","author":"Krolak","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/cns.13560","article-title":"Endothelial glycocalyx as an important factor in composition of blood\u2013brain barrier","volume":"27","author":"Zhao","year":"2020","journal-title":"CNS Neurosci Ther"},{"issue":"8056","key":"10.1016\/j.pharmr.2026.100118_bib41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41586-025-08589-9","article-title":"Glycocalyx dysregulation impairs blood\u2013brain barrier in ageing and disease","volume":"639","author":"Shi","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252416","article-title":"Exploring the mechanism of hyperpermeability following glycocalyx degradation: beyond the glycocalyx as a structural barrier","volume":"16","author":"Abe","year":"2021","journal-title":"PLOS One"},{"issue":"7323","key":"10.1016\/j.pharmr.2026.100118_bib43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood-brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2026.100118_bib44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-5-32","article-title":"Pericyte-specific expression of PDGF\u03b2 receptor in mouse models","volume":"5","author":"Winkler","year":"2010","journal-title":"Mol Neurodegener"},{"issue":"48","key":"10.1016\/j.pharmr.2026.100118_bib45","article-title":"Integrin \u03b18-mediated pericyte morphogenesis controls blood-brain barrier integrity","volume":"12","author":"Gong","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100052","article-title":"The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: the aberrant pericyte is a central player","volume":"77","author":"Divecha","year":"2025","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer\u2019s disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2026.100118_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.575690","article-title":"Astrocytic sonic hedgehog alleviates intracerebral hemorrhagic brain injury via modulation of blood-brain barrier integrity","volume":"14","author":"Xing","year":"2020","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/jnc.14064","article-title":"Sonic hedgehog signalling mediates astrocyte crosstalk with neurons to confer neuroprotection","volume":"142","author":"Ugbode","year":"2017","journal-title":"J Neurochem"},{"issue":"41","key":"10.1016\/j.pharmr.2026.100118_bib50","doi-asserted-by":"crossref","first-page":"13597","DOI":"10.1523\/JNEUROSCI.0830-10.2010","article-title":"Sonic hedgehog regulates discrete populations of astrocytes in the adult mouse forebrain","volume":"30","author":"Garcia","year":"2010","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNR.0b013e3282f2b4eb","article-title":"Altered blood-brain barrier integrity in adult aquaporin-4 knockout mice","volume":"19","author":"Zhou","year":"2008","journal-title":"NeuroReport"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2007.08.007","article-title":"Aquaporin-4 independent Kir4.1 K+ channel function in brain glial cells","volume":"37","author":"Zhang","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmr.2026.100118_bib53","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.95873","article-title":"Astrocyte aquaporin mediates a tonic water efflux maintaining brain homeostasis","volume":"13","author":"Pham","year":"2024","journal-title":"eLife"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2019.1651157","article-title":"The extracellular matrix of the blood-brain barrier: structural and functional roles in health, aging, and Alzheimer\u2019s disease","volume":"7","author":"Reed","year":"2019","journal-title":"Tissue Barriers"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib55","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/jnc.13747","article-title":"Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood-brain barrier","volume":"140","author":"Thomsen","year":"2017","journal-title":"J Neurochem"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib56","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1097\/01.LAB.0000042240.52093.0F","article-title":"Neurologic defects and selective disruption of basement membranes in mice lacking entactin-1\/nidogen-1","volume":"82","author":"Dong","year":"2002","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib57","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1038\/s41467-025-61888-7","article-title":"Mechanobiology of the blood-brain barrier during development, disease and ageing","volume":"16","author":"K\u00f6nig","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cns.13569","article-title":"Peripheral inflammation and blood\u2013brain barrier disruption: effects and mechanisms","volume":"27","author":"Huang","year":"2020","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib59","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/brain\/123.4.687","article-title":"Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1","volume":"123","author":"Kallmann","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.pharmr.2026.100118_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.965169","article-title":"The role of neutrophils in the dysfunction of central nervous system barriers","volume":"14","author":"Santos-Lima","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib61","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/ars.2008.2204","article-title":"Hug tightly and say goodbye: role of endothelial ICAM-1 in leukocyte transmigration","volume":"11","author":"Rahman","year":"2009","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100118_bib62","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20242154","article-title":"Aging microvasculature: effects on immune cell trafficking and inflammatory diseases","volume":"222","author":"Reglero-Real","year":"2025","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib63","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.4049\/jimmunol.164.12.6487","article-title":"Neutrophil-induced changes in the biomechanical properties of endothelial cells: roles of ICAM-1 and reactive oxygen species","volume":"164","author":"Wang","year":"2000","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib64","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1189\/jlb.3RU0816-352RR","article-title":"Endothelial cell activation in central nervous system inflammation","volume":"101","author":"Wu","year":"2017","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-7771-2-1","article-title":"Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases","volume":"2","author":"Yang","year":"2014","journal-title":"Biomark Res"},{"key":"10.1016\/j.pharmr.2026.100118_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1196033","article-title":"Monocyte\u2013endothelial cell interactions in vascular and tissue remodeling","volume":"14","author":"Medrano-Bosch","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100118_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1101379","article-title":"The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis","volume":"17","author":"Angelini","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.pharmr.2026.100118_bib68","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3389\/fimmu.2019.03056","article-title":"Intercellular adhesion molecule-1 (ICAM-1) and ICAM-2 differentially contribute to peripheral activation and CNS entry of autoaggressive Th1 and Th17 cells in experimental autoimmune encephalomyelitis","volume":"10","author":"Haghayegh Jahromi","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib69","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/s41593-019-0497-x","article-title":"Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood-brain barrier dysfunction module","volume":"22","author":"Munji","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmr.2026.100118_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661838","article-title":"Blood-brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction","volume":"15","author":"Takata","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib71","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","article-title":"Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat","volume":"27","author":"Yang","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/716c0fb2-dbdd-4da5-ad8a-d2b1cdac4ec6","article-title":"Matrix metalloproteinase-2 and \u22129 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins","volume":"6","author":"Feng","year":"2011","journal-title":"PLOS One"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib73","first-page":"197","article-title":"Altered expression of matrix metalloproteinases and tight junction proteins in rats following PEMF-induced BBB permeability change","volume":"25","author":"Zhang","year":"2012","journal-title":"Biomed Environ Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib74","doi-asserted-by":"crossref","first-page":"C951","DOI":"10.1152\/ajpcell.00342.2023","article-title":"Ozanimod differentially preserves human cerebrovascular endothelial barrier proteins and attenuates matrix metalloproteinase-9 activity following in vitro acute ischemic injury","volume":"325","author":"Wendt","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib75","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","article-title":"Blood-brain barrier tight junction permeability and ischemic stroke","volume":"32","author":"Sandoval","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100118_bib76","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500697R","article-title":"ADAM8 destroys the endothelial barrier and promotes leukocyte extravasation to aggravate hepatic ischemia\u2013reperfusion injury","volume":"39","author":"Li","year":"2025","journal-title":"FASEB J"},{"issue":"2-suppl","key":"10.1016\/j.pharmr.2026.100118_bib77","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.STR.0000253500.32979.d1","article-title":"Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke","volume":"38","author":"Zhao","year":"2007","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib78","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.neuroscience.2008.08.028","article-title":"Inflammation and the neurovascular unit in the setting of focal cerebral ischemia","volume":"158","author":"del Zoppo","year":"2009","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib79","article-title":"Increase in blood-brain barrier (BBB) permeability is regulated by MMP3 via the ERK signaling pathway","volume":"2021","author":"Zhang","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100118_bib80","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.3390\/ijms25137383","article-title":"MMP-3 knockout induces global transcriptional changes and reduces cerebral infarction in both male and female models of ischemic stroke","volume":"25","author":"Hamblin","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib81","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1124\/dmd.112.044719","article-title":"Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp\/Bcrp knockout mice","volume":"40","author":"Agarwal","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib82","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/scipharm87010006","article-title":"Overcoming the blood\u2013brain barrier. Challenges and tricks for CNS drug delivery","volume":"87","author":"Bors","year":"2019","journal-title":"Sci Pharm"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib83","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12987-024-00562-4","article-title":"ATP-binding cassette transporter inhibitor potency and substrate drug affinity are critical determinants of successful drug delivery enhancement to the brain","volume":"21","author":"Lentzas","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib84","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/cpt.1710","article-title":"Protein expression and functional relevance of efflux and uptake drug transporters at the blood-brain barrier of human brain and glioblastoma","volume":"107","author":"Bao","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib85","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/jpet.109.162321","article-title":"Kinetic analysis of the cooperation of P-glycoprotein (P-gp\/Abcb1) and breast cancer resistance protein (Bcrp\/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone","volume":"333","author":"Kodaira","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib86","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s11095-023-03598-7","article-title":"Functional evaluation of P-gp and Bcrp at the murine blood\u2013cerebrospinal fluid barrier","volume":"40","author":"Sun","year":"2023","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib87","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/pharmaceutics13081286","article-title":"Assessing the functional redundancy between P-gp and Bcrp in controlling the brain distribution and biliary excretion of dual substrates with PET imaging in mice","volume":"13","author":"Hern\u00e1ndez-Lozano","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib88","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1124\/dmd.108.024646","volume":"37","author":"Polli","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib89","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s10637-019-00806-3","article-title":"The influence of the coadministration of the p-glycoprotein modulator elacridar on the pharmacokinetics of lapatinib and its distribution in the brain and cerebrospinal fluid","volume":"38","author":"Karbownik","year":"2019","journal-title":"Investig New Drugs"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib90","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1158\/1535-7163.MCT-10-0197","article-title":"A synergistic interaction between lapatinib and chemotherapy agents in a panel of cell lines is due to the inhibition of the efflux pump BCRP","volume":"9","author":"Perry","year":"2010","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib91","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/cpt.64","article-title":"Regulation of ABC transporters at the blood-brain barrier","volume":"97","author":"Miller","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib92","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.102.035014","article-title":"Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition","volume":"302","author":"Gerk","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2026.100118_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.561936","article-title":"Clinical perspective of FDA approved drugs with P-glycoprotein inhibition activities for potential cancer therapeutics","volume":"10","author":"Lai","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib94","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/ijms26031124","article-title":"The role of elacridar, a P-gp inhibitor, in the re-sensitization of PAC-resistant ovarian cancer cell lines to cytotoxic drugs in 2D and 3D cell culture models","volume":"26","author":"Stasiak","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib95","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s13318-017-0411-4","article-title":"Therapeutic potential and utility of elacridar with respect to P-glycoprotein inhibition: an insight from the published in vitro, preclinical and clinical studies","volume":"42","author":"Dash","year":"2017","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib96","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/dmd.115.067785","article-title":"Tariquidar is an inhibitor and not a substrate of human and mouse P-glycoprotein","volume":"44","author":"Weidner","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib97","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2967\/jnumed.109.063289","article-title":"A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood\u2013brain barrier with (R)-11C-verapamil and PET","volume":"50","author":"Wagner","year":"2009","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100118_bib98","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2967\/jnumed.118.219972","article-title":"Impact of P-glycoprotein function on the brain kinetics of the weak substrate 11C-metoclopramide assessed with PET imaging in humans","volume":"60","author":"Tournier","year":"2019","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib99","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/clpt.2013.175","article-title":"Profiling solute carrier transporters in the human blood-brain barrier","volume":"94","author":"Geier","year":"2013","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173474","article-title":"Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB)","volume":"12","author":"Sekhar","year":"2017","journal-title":"PLOS One"},{"key":"10.1016\/j.pharmr.2026.100118_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114181","article-title":"Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats","volume":"357","author":"Stanton","year":"2022","journal-title":"Exp Neurol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib102","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1161\/STROKEAHA.123.043649","article-title":"Oatp (organic anion transporting polypeptide)-mediated transport: a mechanism for atorvastatin neuroprotection in stroke","volume":"54","author":"Williams","year":"2023","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib103","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1191\/1352458503ms965oa","article-title":"Blood-brain barrier disruption in multiple sclerosis","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult Scler"},{"key":"10.1016\/j.pharmr.2026.100118_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103136","article-title":"Circulating levels of tight junction proteins in multiple sclerosis: association with inflammation and disease activity before and after disease modifying therapy","volume":"54","author":"Olsson","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib105","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41419-022-04888-5","article-title":"Endothelial ETS1 inhibition exacerbate blood-brain barrier dysfunction in multiple sclerosis through inducing endothelial-to-mesenchymal transition","volume":"13","author":"Luo","year":"2022","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12782","article-title":"Dysfunction of the blood-brain barrier in Alzheimer\u2019s disease: evidence from human studies","volume":"48","author":"Kurz","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib107","doi-asserted-by":"crossref","first-page":"8615","DOI":"10.1002\/alz.14302","article-title":"APOE \u03b54-related blood-brain barrier breakdown is associated with microstructural abnormalities\u2019","volume":"20","author":"Reas","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib108","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000734","article-title":"Targeting miR-27a\/VE-cadherin interactions rescues cerebral cavernous malformations in mice","volume":"18","author":"Li","year":"2020","journal-title":"PLOS Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.21037\/atm-21-6679","article-title":"Sphingosine 1-phosphate receptor 1 governs endothelial barrier function and angiogenesis by upregulating endoglin signaling","volume":"10","author":"Wang","year":"2022","journal-title":"Ann Transl Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib111","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.3390\/ijms24044018","article-title":"Dialogue between VE-cadherin and sphingosine 1 phosphate Receptor1 (S1PR1) for protecting endothelial functions","volume":"24","author":"Garnier","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100118_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/srep19814","article-title":"Regulation of human cerebro-microvascular endothelial baso-lateral adhesion and barrier function by S1P through dual involvement of S1P1 and S1P2 receptors","volume":"6","author":"Wiltshire","year":"2016","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib113","first-page":"1763","article-title":"Sphingosine 1-phosphate receptor 1 regulates blood-brain barrier permeability in epileptic mice","volume":"18","author":"Yang","year":"2023","journal-title":"Neural Regen Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib114","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","article-title":"Social stress induces neurovascular pathology promoting depression","volume":"20","author":"Menard","year":"2017","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11095-022-03179-0","article-title":"Differences in cerebral distribution between imipramine and paroxetine via membrane transporters at the rat blood-brain barrier","volume":"39","author":"Akanuma","year":"2022","journal-title":"Pharm Res"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100118_bib116","article-title":"Development of novel therapeutics targeting the blood-brain barrier: from barrier to carrier","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib117","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/ATVBAHA.118.310822","article-title":"MicroRNA-mediated therapy modulating blood-brain barrier disruption improves vascular cognitive impairment","volume":"38","author":"Toyama","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"626","key":"10.1016\/j.pharmr.2026.100118_bib118","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aay5686","article-title":"Endothelium-targeted deletion of the miR-15a\/16-1 cluster ameliorates blood-brain barrier dysfunction in ischemic stroke","volume":"13","author":"Ma","year":"2020","journal-title":"Sci Signal"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib119","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12987-025-00639-8","article-title":"Rutin ameliorates stress-induced blood\u2012brain barrier dysfunction and cognitive decline via the endothelial HDAC1\u2012Claudin-5 axis","volume":"22","author":"Sun","year":"2025","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1083\/jcb.200806024","article-title":"Wnt\/\u03b2-catenin signaling controls development of the blood-brain barrier","volume":"183","author":"Liebner","year":"2008","journal-title":"J Cell Biol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib121","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1093\/brain\/awac236","article-title":"Activation of Wnt\/\u03b2-catenin pathway mitigates blood\u2013brain barrier dysfunction in Alzheimer\u2019s disease","volume":"145","author":"Wang","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.pharmr.2026.100118_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.895429","article-title":"Endothelial \u03b2-catenin deficiency causes blood-brain barrier breakdown via enhancing the paracellular and transcellular permeability","volume":"15","author":"Hussain","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.pharmr.2026.100118_bib123","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70992","article-title":"Wnt signaling mediates acquisition of blood-brain barrier properties in na\u00efve endothelium derived from human pluripotent stem cells","volume":"10","author":"Gastfriend","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.pharmr.2026.100118_bib124","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2017.51","article-title":"Discovery of a ROCK inhibitor, FPND, which prevents cerebral hemorrhage through maintaining vascular integrity by interference with VE-cadherin","volume":"3","author":"Li","year":"2017","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12987-022-00336-w","article-title":"Effects of fasudil on blood\u2013brain barrier integrity","volume":"19","author":"Sato","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.pharmr.2026.100118_bib126","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.102794.3","article-title":"Rho-ROCK liberates sequestered claudin for rapid de novo tight junction formation","volume":"13","author":"Cho","year":"2025","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib127","first-page":"16","article-title":"Rho signaling and tight junction functions","volume":"25","author":"Terry","year":"2010","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/CIRCRESAHA.116.306534","article-title":"Protein interactions at endothelial junctions and signaling mechanisms regulating endothelial permeability","volume":"120","author":"Komarova","year":"2017","journal-title":"Circ Res"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100118_bib129","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1093\/emboj\/cdf688","article-title":"Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression","volume":"21","author":"Tzima","year":"2002","journal-title":"EMBO J"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00418-005-0080-2","article-title":"Activation of Rac-1 and Cdc42 stabilizes the microvascular endothelial barrier","volume":"125","author":"Waschke","year":"2006","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.pharmr.2026.100118_bib131","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","article-title":"NF-\u03baB signaling pathways in neurological inflammation: a mini review","volume":"8","author":"Shih","year":"2015","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib132","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000331720","article-title":"NF\u0138B is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia","volume":"28","author":"Stone","year":"2011","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib133","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12987-025-00713-1","article-title":"Role of transforming growth factor\u03b2 in neurovascular unit during cerebral small vessel disease","volume":"22","author":"Li","year":"2025","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.pharmr.2026.100118_bib134","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40478-014-0096-8","article-title":"Sequestration of latent TGF-\u03b2 binding protein 1 into CADASIL-related notch3-ECD deposits","volume":"2","author":"Kast","year":"2014","journal-title":"Acta Neuropathol Commun"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100118_bib135","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2417224122","article-title":"Inhibiting 15-PGDH blocks blood-brain barrier deterioration and protects mice from Alzheimer\u2019s disease and traumatic brain injury","volume":"122","author":"Koh","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib136","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq2616","article-title":"A claudin5-binding peptide enhances the permeability of the blood-brain barrier in vitro","volume":"11","author":"Trevisani","year":"2025","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib137","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41467-022-28785-9","article-title":"Endothelial Unc5B controls blood-brain barrier integrity","volume":"13","author":"Boy\u00e9","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib138","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41596-021-00634-x","article-title":"Hyperosmolar blood\u2013brain barrier opening using intra-arterial injection of hyperosmotic mannitol in mice under real-time MRI guidance","volume":"17","author":"Chu","year":"2021","journal-title":"Nat Protoc"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib139","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1172\/JCI109509","article-title":"Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery","volume":"64","author":"Neuwelt","year":"1979","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3171\/jns.2000.92.4.0599","article-title":"In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans","volume":"92","author":"Siegal","year":"2000","journal-title":"J Neurosurg"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100118_bib141","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.3390\/ijms25189792","article-title":"Assessment of mannitol-induced chronic blood\u2013brain barrier dysfunction in vivo using magnetic resonance","volume":"25","author":"Sampedro-Viana","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100118_bib142","article-title":"Excess salt exacerbates blood-brain barrier disruption via a p38\/MAPK\/SGK1-dependent pathway in permanent cerebral ischemia","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib143","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12028-020-00959-7","article-title":"Guidelines for the acute treatment of cerebral edema in neurocritical care patients","volume":"32","author":"Cook","year":"2020","journal-title":"Neurocrit Care"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib144","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bcp.2014.10.006","article-title":"Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation","volume":"92","author":"Loo","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib145","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/pharmrev.120.000025","article-title":"ABCB1 and ABCG2 regulation at the blood-brain barrier: potential new targets to improve brain drug delivery","volume":"75","author":"Schulz","year":"2023","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2026.100118_bib146","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejps.2018.04.026","article-title":"Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: a potent approach to treat amyotrophic lateral sclerosis","volume":"120","author":"Yang","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib147","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development","volume":"20","author":"Choi","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib148","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00280-003-0720-y","article-title":"The Influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice","volume":"53","author":"Kemper","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib149","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2967\/jnumed.108.059162","article-title":"Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans","volume":"50","author":"Muzi","year":"2009","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib150","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1124\/dmd.114.058685","article-title":"Modulation of P-glycoprotein at the human blood-brain barrier by quinidine or rifampin treatment: a positron emission tomography imaging study","volume":"43","author":"Liu","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib151","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejps.2007.06.007","article-title":"Increased uptake of quinine into the brain by inhibition of P-glycoprotein","volume":"32","author":"Pussard","year":"2007","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib152","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2967\/jnumed.114.146894","article-title":"Increased permeability-glycoprotein inhibition at the human blood-brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar","volume":"56","author":"Kreisl","year":"2015","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib153","doi-asserted-by":"crossref","DOI":"10.4161\/tisb.24565","article-title":"Trends in drug delivery through tissue barriers containing tight junctions","volume":"1","author":"Tscheik","year":"2013","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.pharmr.2026.100118_bib154","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2018.05.010","article-title":"Angubindin-1 opens the blood\u2013brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system","volume":"283","author":"Zeniya","year":"2018","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib155","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.bbamem.2008.09.016","article-title":"Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery","volume":"1788","author":"Deli","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2026.100118_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.791709","article-title":"The bradykinin B2 receptor agonist (NG291) causes rapid onset of transient blood\u2013brain barrier disruption without evidence of early brain injury","volume":"15","author":"Rodr\u00edguez-Mass\u00f3","year":"2021","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib157","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12987-025-00693-2","article-title":"High-affinity transferrin receptor binding improves brain delivery of bispecific antibodies at tracer dose","volume":"22","author":"Bonvicini","year":"2025","journal-title":"Fluids Barriers CNS"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100118_bib158","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.tips.2025.08.006","article-title":"Beyond the blood\u2013brain barrier: the fate of transcytosed therapeutics","volume":"46","author":"Baghirov","year":"2025","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib159","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2261509","article-title":"Delivery of the Brainshuttle\u2122 amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans","volume":"15","author":"Grimm","year":"2023","journal-title":"mAbs"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100214","article-title":"Bispecific brain-penetrant antibodies for treatment of Alzheimer\u2019s disease","volume":"12","author":"Sehlin","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.pharmr.2026.100118_bib161","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3389\/fnins.2018.01019","article-title":"Transcytosis to cross the blood brain barrier, new advancements and challenges","volume":"12","author":"Pulgar","year":"2019","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib162","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12987-020-00209-0","article-title":"Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human","volume":"17","author":"Zhang","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib163","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1124\/jpet.111.185876","article-title":"Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitor","volume":"339","author":"Zhou","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib164","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/JVI.02154-14","article-title":"Expression of neuronal CXCL10 induced by rabies virus infection initiates infiltration of inflammatory cells, production of chemokines and cytokines, and enhancement of blood-brain barrier permeability","volume":"89","author":"Chai","year":"2014","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100118_bib165","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/JVI.03149-13","article-title":"Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines\/cytokines induced by rabies virus infection","volume":"88","author":"Chai","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib166","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/ph18010104","article-title":"Targeting cytokine-mediated inflammation in brain disorders: developing new treatment strategies","volume":"18","author":"Mallick","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"824","key":"10.1016\/j.pharmr.2026.100118_bib167","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adq6645","article-title":"Blood-brain barrier opening with neuronavigation-guided focused ultrasound in pediatric patients with diffuse midline glioma","volume":"17","author":"Wu","year":"2025","journal-title":"Sci Transl Med"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100118_bib168","doi-asserted-by":"crossref","first-page":"10028","DOI":"10.7150\/thno.98098","article-title":"Ultrasound flow imaging for assessing cerebrovascular changes following focused-ultrasound blood-brain barrier opening","volume":"15","author":"Bae","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib169","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73312-9","article-title":"Consistent opening of the blood brain barrier using focused ultrasound with constant intravenous infusion of microbubble agent","volume":"10","author":"Lapin","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11060-024-04795-z","article-title":"Focused ultrasound-mediated enhancement of blood\u2013brain barrier permeability for brain tumor treatment: a systematic review of clinical trials","volume":"170","author":"Zhu","year":"2024","journal-title":"J Neurooncol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100118_bib171","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2174\/1570159X20666220201092908","article-title":"Potential goals, challenges, and safety of focused ultrasound application for central nervous system disorders","volume":"20","author":"P\u00e9rez-Neri","year":"2022","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib172","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12987-022-00402-3","article-title":"New insight into the inflammatory response following focused ultrasound-mediated blood\u2013brain barrier disruption","volume":"19","author":"Choi","year":"2022","journal-title":"Fluids Barriers CNS"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib173","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.7150\/thno.24181","article-title":"Focused ultrasound with microbubbles induces sterile inflammatory response proportional to the blood brain barrier opening: attention to experimental conditions","volume":"8","author":"Kovacs","year":"2018","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib174","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/jcm14020386","article-title":"The crucial role of the blood\u2013brain barrier in neurodegenerative diseases: mechanisms of disruption and therapeutic implications","volume":"14","author":"Kim","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.pharmr.2026.100118_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114905","article-title":"Storming the gate: new approaches for targeting the dynamic tight junction for improved drug delivery","volume":"199","author":"Ramirez-Velez","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055972","article-title":"Inhibition of glycogen synthase kinase 3\u03b2 promotes tight junction stability in brain endothelial cells by half-life extension of occludin and claudin-5","volume":"8","author":"Ramirez","year":"2013","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib177","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/MCB.23.1.14-25.2003","article-title":"Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis","volume":"23","author":"Liu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmr.2026.100118_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.642352","article-title":"Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective","volume":"9","author":"Akil","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib179","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1242\/dev.003244","article-title":"Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis","volume":"134","author":"Leslie","year":"2007","journal-title":"Development"},{"key":"10.1016\/j.pharmr.2026.100118_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.148071","article-title":"Targeting the blood-brain barrier disruption in hypertension by ALK5\/TGF-\u0392 type I receptor inhibitor SB-431542 and dynamin inhibitor dynasore","volume":"1794","author":"Atis","year":"2022","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2026.100118_bib181","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jare.2024.01.016","article-title":"Role of endothelial cell\u2013pericyte interactions in vascularization and diseases","volume":"67","author":"Li","year":"2025","journal-title":"J Adv Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib182","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/jcbfm.2009.32","article-title":"Transforming growth factor-\u03b2 signaling alters substrate permeability and tight junction protein expression at the blood\u2013brain barrier during inflammatory pain","volume":"29","author":"Ronaldson","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2026.100118_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107101","article-title":"The VEGFs\/VEGFRs system in Alzheimer\u2019s and Parkinson\u2019s diseases: pathophysiological roles and therapeutic implications","volume":"201","author":"Ceci","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmr.2026.100118_bib184","doi-asserted-by":"crossref","DOI":"10.1177\/26331055221109254","article-title":"VEGF paradoxically reduces cerebral blood flow in Alzheimer\u2019s disease mice","volume":"17","author":"Ali","year":"2022","journal-title":"Neurosci Insights"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib185","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/jcbfm.2011.97","article-title":"Coexpression of angiopoietin-1 with VEGF increases the structural integrity of the blood\u2013brain barrier and reduces atrophy volume","volume":"31","author":"Shen","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib186","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-016-1551-3","article-title":"Angiopoietin-2\u2013induced blood\u2013brain barrier compromise and increased stroke size are rescued by VE-PTP\u2013dependent restoration of Tie2 signaling","volume":"131","author":"Gurnik","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharmr.2026.100118_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.03.004","article-title":"Angioneurins\u2014Key regulators of blood-brain barrier integrity during hypoxic and ischemic brain injury","volume":"178","author":"Kunze","year":"2019","journal-title":"Prog Neurobiol"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100118_bib188","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1074\/jbc.275.13.9102","article-title":"Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt\/survivin pathway","volume":"275","author":"Papapetropoulos","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib189","first-page":"213","article-title":"Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors","volume":"79","author":"Papapetropoulos","year":"1999","journal-title":"Lab Invest"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib190","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1167\/iovs.08-3174","article-title":"Doxycycline-mediated inhibition of choroidal neovascularization","volume":"50","author":"Samtani","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmr.2026.100118_bib191","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuroscience.2019.06.038","article-title":"Minocycline preserves the integrity and permeability of BBB by altering the activity of DKK1-Wnt signaling in ICH model","volume":"415","author":"Wang","year":"2019","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib192","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41598-022-09394-4","article-title":"Doxycycline prevents blood\u2013brain barrier dysfunction and microvascular hyperpermeability after traumatic brain injury","volume":"12","author":"Robinson","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib193","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1471-4892(02)00184-4","article-title":"Drug inhibition of angiogenesis","volume":"2","author":"Madhusudan","year":"2002","journal-title":"Curr Opin Pharmacol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib194","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4390","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibition?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib195","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","article-title":"Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology","volume":"74","author":"de Almeida","year":"2022","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib196","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s10020-024-01025-0","article-title":"The pleiotropic effects of statins: a comprehensive exploration of neurovascular unit modulation and blood\u2013brain barrier protection","volume":"30","author":"Liu","year":"2024","journal-title":"Mol Med"},{"key":"10.1016\/j.pharmr.2026.100118_bib197","article-title":"Simvastatin blocks blood-brain barrier disruptions induced by elevated cholesterol both in vivo and in vitro","volume":"2012","author":"Jiang","year":"2012","journal-title":"Int J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib198","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4236\/jbbs.2013.31010","article-title":"Statins protect the blood brain barrier acutely after experimental intracerebral hemorrhage","volume":"3","author":"Yang","year":"2013","journal-title":"J Behav Brain Sci"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100118_bib199","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/jcbfm.2015.38","article-title":"Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein","volume":"35","author":"Hue","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12974-018-1318-y","article-title":"Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery-a randomized trial","volume":"15","author":"Danielson","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib201","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drudis.2019.09.009","article-title":"Neurovascular glucocorticoid receptors and glucocorticoids: implications in health, neurological disorders and drug therapy","volume":"25","author":"Williams","year":"2020","journal-title":"Drug Discov Today"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100118_bib202","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1113\/jphysiol.2011.218156","article-title":"Losartan abolishes oxidative stress induced by intermittent hypoxia in humans","volume":"589","author":"Pialoux","year":"2011","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib203","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1038\/s41598-022-13772-3","article-title":"Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects","volume":"12","author":"Tehrani","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100118_bib204","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2008.09.074","article-title":"PPAR\u03b3 agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms","volume":"1244","author":"Yi","year":"2008","journal-title":"Brain Res"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100118_bib205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112781","article-title":"Pioglitazone attenuates the effects of peripheral inflammation in a human in vitro blood\u2013brain barrier model","volume":"23","author":"da Rocha","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib206","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3892\/etm.2014.1840","article-title":"Progesterone protects blood-brain barrier function and improves neurological outcome following traumatic brain injury in rats","volume":"8","author":"Si","year":"2014","journal-title":"Exp Ther Med"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100118_bib207","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1210\/ME.2015-1124","article-title":"17\u03b2-estradiol ameliorates tight junction disruption via repression of MMP transcription","volume":"29","author":"Na","year":"2015","journal-title":"Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib208","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3727\/000000006781510723","article-title":"Guarding the blood\u2013brain barrier: a role for estrogen in the etiology of neurodegenerative disease","volume":"13","author":"Sohrabji","year":"2007","journal-title":"Gene Expr"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib209","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00259-020-05166-2","article-title":"Cellular sources of TSPO expression in healthy and diseased brain","volume":"49","author":"Nutma","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib210","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","article-title":"Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function","volume":"27","author":"Papadopoulos","year":"2006","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib211","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.14348\/molcells.2015.0165","article-title":"The 18-kDa translocator protein inhibits vascular cell adhesion molecule-1 expression via inhibition of mitochondrial reactive oxygen species","volume":"38","author":"Joo","year":"2015","journal-title":"Mol Cells"},{"issue":"B","key":"10.1016\/j.pharmr.2026.100118_bib212","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biochi.2025.08.002","article-title":"TSPO, reactive oxygen species and oxidative stress in physiological and pathological situations: a complex relationship","volume":"238","author":"Morin","year":"2025","journal-title":"Biochimie"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib213","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1096\/fj.201601377RR","article-title":"A TSPO ligand attenuates brain injury after intracerebral hemorrhage","volume":"31","author":"Li","year":"2017","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib214","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12974-019-1424-5","article-title":"The agonistic TSPO ligand XBD173 attenuates the glial response thereby protecting inner retinal neurons in a murine model of retinal ischemia","volume":"16","author":"Mages","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib215","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib216","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2174\/011574888X266357230923113642","article-title":"The miR-210 primed endothelial progenitor cell exosomes alleviate acute ischemic brain injury","volume":"19","author":"Wang","year":"2024","journal-title":"Curr Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib217","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib218","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1006995910836","article-title":"Tight junctions of the blood-brain barrier","volume":"20","author":"Kniesel","year":"2000","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib219","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/pharmaceutics14050894","article-title":"Application of CRISPR-Cas9 system to study biological barriers to drug delivery","volume":"14","author":"He","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib220","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib221","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12964-023-01142-z","article-title":"Physiological and pathological consequences of exosomes at the blood-brain-barrier interface","volume":"21","author":"Salimi","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib222","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13287-020-01761-0","article-title":"miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury","volume":"11","author":"Pan","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.pharmr.2026.100118_bib223","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2025.1639756","article-title":"Mesenchymal stem cells and exosomes in ischemic brain injury: a review","volume":"16","author":"Xu","year":"2025","journal-title":"Front Genet"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib224","first-page":"1227","article-title":"Astrocyte-derived extracellular vesicles for ischemic stroke: therapeutic potential and prospective","volume":"15","author":"Wang","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.pharmr.2026.100118_bib225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuroscience.2024.09.040","article-title":"Therapeutic potential of astrocyte-derived extracellular vesicles in mitigating cytotoxicity and transcriptome changes in human brain endothelial cells","volume":"560","author":"Stewart","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmr.2026.100118_bib226","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2020.04.017","article-title":"Astrocyte-derived extracellular vesicles: neuroreparative properties and role in the pathogenesis of neurodegenerative disorders","volume":"323","author":"Upadhya","year":"2020","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib227","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12964-023-01165-6","article-title":"Roles and therapeutic potential of different extracellular vesicle subtypes on traumatic brain injury","volume":"21","author":"Dong","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.pharmr.2026.100118_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111256","article-title":"Exosome-based platforms for treatment of multiple sclerosis","volume":"222","author":"Zonouz","year":"2025","journal-title":"Brain Res Bull"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib229","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.3390\/ijms24087470","article-title":"Astrocyte-derived exosomes differentially shape T cells\u2019 immune response in MS patients","volume":"24","author":"Szpakowski","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib230","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1039\/D4BM01394H","article-title":"Extracellular vesicles as drug and gene delivery vehicles in central nervous system diseases","volume":"13","author":"Shi","year":"2025","journal-title":"Biomater Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib231","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12987-022-00359-3","article-title":"Extracellular vesicles through the blood\u2013brain barrier: a review","volume":"19","author":"Ramos-Zald\u00edvar","year":"2022","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib232","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13770-022-00503-y","article-title":"Engineered extracellular vesicles as a targeted delivery platform for precision therapy","volume":"20","author":"Sun","year":"2023","journal-title":"Tissue Eng Regen Med"},{"key":"10.1016\/j.pharmr.2026.100118_bib233","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jconrel.2023.03.009","article-title":"Engineered EVs designed to target diseases of the CNS","volume":"356","author":"Nieland","year":"2023","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib234","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13287-025-04285-7","article-title":"Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases","volume":"16","author":"Deng","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12987-019-0136-7","article-title":"Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D","volume":"16","author":"Jamieson","year":"2019","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib236","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4103\/1673-5374.177739","article-title":"Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain","volume":"11","author":"Ryu","year":"2016","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.pharmr.2026.100118_bib237","article-title":"Transplantation of layer-by-layer assembled neural stem cells tethered with vascular endothelial growth factor reservoir promotes neurogenesis and angiogenesis after ischemic stroke in mice","volume":"28","author":"Ge","year":"2022","journal-title":"Appl Mater Today"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib238","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s13287-022-03122-5","article-title":"Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach","volume":"13","author":"Yari","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.pharmr.2026.100118_bib239","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1536028","article-title":"Blood-brain barrier repair: potential and challenges of stem cells and exosomes in stroke treatment","volume":"19","author":"Fu","year":"2025","journal-title":"Front Cell Neurosci"},{"issue":"183","key":"10.1016\/j.pharmr.2026.100118_bib240","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005338","article-title":"Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier","volume":"5","author":"Couch","year":"2013","journal-title":"Sci Transl Med"},{"issue":"545","key":"10.1016\/j.pharmr.2026.100118_bib241","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1359","article-title":"Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys","volume":"12","author":"Kariolis","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pharmr.2026.100118_bib242","doi-asserted-by":"crossref","DOI":"10.1038\/srep14104","article-title":"Cargo delivery into the brain by in vivo identified transport peptides","volume":"5","author":"Urich","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib243","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1042\/BST20220830","article-title":"Role of the blood\u2013brain barrier during neurological disease and infection","volume":"51","author":"Patabendige","year":"2023","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmr.2026.100118_bib244","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jconrel.2020.05.040","article-title":"Secondary effects on brain physiology caused by focused ultrasound-mediated disruption of the blood\u2013brain barrier","volume":"324","author":"Todd","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.pharmr.2026.100118_bib245","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1143157","article-title":"Off-target effects in CRISPR\/Cas9 gene editing","volume":"11","author":"Guo","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib246","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/s41596-018-0066-x","article-title":"Blood\u2013brain-barrier organoids for investigating the permeability of CNS therapeutics","volume":"13","author":"Bergmann","year":"2018","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib247","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41467-019-13896-7","article-title":"Microengineered human blood\u2013brain barrier platform for understanding nanoparticle transport mechanisms","volume":"11","author":"Ahn","year":"2020","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib248","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104813","article-title":"A microengineered brain-chip to model neuroinflammation in humans","volume":"25","author":"Pediaditakis","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.pharmr.2026.100118_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.ooc.2023.100027","article-title":"Blood\u2013brain barrier microfluidic chips and their applications","volume":"5","author":"Li","year":"2023","journal-title":"Organs-on-a-Chip"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12951-023-01798-2","article-title":"BBB-on-a-chip with integrated micro-TEER for permeability evaluation of multi-functionalized gold nanorods against Alzheimer\u2019s disease","volume":"21","author":"Palma-Florez","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.pharmr.2026.100118_bib251","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ebiom.2016.02.023","article-title":"Modeling barrier tissues in vitro: methods, achievements, and challenges","volume":"5","author":"Sakolish","year":"2016","journal-title":"EBiomedicine"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib252","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/pharmaceutics16050574","article-title":"Evaluation of drug blood-brain-barrier permeability using a microfluidic chip","volume":"16","author":"Yang","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib253","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ad0260","article-title":"A 3D-printed blood\u2013brain barrier model with tunable topology and cell\u2013matrix interactions","volume":"16","author":"Paone","year":"2023","journal-title":"Biofabrication"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib254","article-title":"Generation of advanced blood-brain barrier spheroids using human-induced pluripotent stem cell-derived brain capillary endothelial-like cells","volume":"9","author":"Mathew-Schmitt","year":"2025","journal-title":"Adv Biol (Weinh)"},{"key":"10.1016\/j.pharmr.2026.100118_bib255","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.715431","article-title":"The use of tissue engineering to fabricate perfusable 3D brain microvessels in vitro","volume":"12","author":"Galpayage Dona","year":"2021","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib256","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15623","article-title":"Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents","volume":"8","author":"Cho","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100118_bib257","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114816","article-title":"An overview of in vitro 3D models of the blood\u2013brain barrier as a tool to predict the in vivo permeability of nanomedicines","volume":"196","author":"P\u00e9rez-L\u00f3pez","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmr.2026.100118_bib258","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.76707","article-title":"Generation of vascularized brain organoids to study neurovascular interactions","volume":"11","author":"Sun","year":"2022","journal-title":"eLife"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib259","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41592-019-0586-5","article-title":"Engineering of human brain organoids with a functional vascular-like system","volume":"16","author":"Cakir","year":"2019","journal-title":"Nat Methods"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100118_bib260","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1007\/s12035-024-03998-9","article-title":"Shaping the neurovascular unit exploiting human brain organoids","volume":"61","author":"Rizzuti","year":"2024","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.pharmr.2026.100118_bib261","article-title":"Vascularization of organoid microenvironments: perfusable networks for organoid growth and maturation","volume":"34","author":"Vila Cuenca","year":"2025","journal-title":"Curr Opin Biomed Eng"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100118_bib262","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1038\/s41380-025-03041-w","article-title":"Alzheimer\u2019s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery","volume":"30","author":"Ji","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib263","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.tibtech.2024.11.021","article-title":"Vascularized human brain organoids: current possibilities and prospects","volume":"43","author":"Kistemaker","year":"2025","journal-title":"Trends Biotechnol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib264","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41467-024-45710-4","article-title":"A microfluidic platform integrating functional vascularized organoids-on-chip","volume":"15","author":"Quintard","year":"2024","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib265","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1039\/D2LC01109C","article-title":"Vascularized human brain organoid on-chip","volume":"23","author":"Tan","year":"2023","journal-title":"Lab Chip"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib266","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.stem.2019.05.011","article-title":"Human iPSC-derived blood\u2013brain barrier chips enable disease modeling and personalized medicine applications","volume":"24","author":"Vatine","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib267","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/jnc.13923","article-title":"An isogenic blood\u2013brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells","volume":"140","author":"Canfield","year":"2017","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib268","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12987-020-00191-7","article-title":"Recent advances in human iPSC-derived models of the blood\u2013brain barrier","volume":"17","author":"Workman","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100118_bib269","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/acschemneuro.3c00743","article-title":"Patient-derived blood\u2013brain barrier model for screening copper bis(thiosemicarbazone) complexes as potential therapeutics in Alzheimer\u2019s disease","volume":"15","author":"Wasielewska","year":"2024","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmr.2026.100118_bib270","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.642812","article-title":"Human induced pluripotent stem cell\u2013derived brain endothelial cells: current controversies","volume":"12","author":"Lu","year":"2021","journal-title":"Front Physiol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib271","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016950118","article-title":"Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate","volume":"118","author":"Lu","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib272","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0271678X16630991","article-title":"In vitro models of the blood\u2013brain barrier: an overview of commonly used brain endothelial cell culture models and guidelines for their use","volume":"36","author":"Helms","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib273","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nbt.2247","article-title":"Derivation of blood\u2013brain barrier endothelial cells from human pluripotent stem cells","volume":"30","author":"Lippmann","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib274","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12987-017-0059-0","article-title":"Accelerated differentiation of human induced pluripotent stem cells to blood\u2013brain barrier endothelial cells","volume":"14","author":"Hollmann","year":"2017","journal-title":"Fluids Barriers CNS"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100118_bib275","doi-asserted-by":"crossref","first-page":"12583","DOI":"10.1021\/acsomega.0c01592","article-title":"Nanocarriers as potential drug delivery candidates for overcoming the blood\u2013brain barrier: challenges and possibilities","volume":"5","author":"Ahlawat","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.pharmr.2026.100118_bib276","article-title":"Advances in nanoparticles in targeted drug delivery\u2013a review","volume":"19","author":"Islam","year":"2025","journal-title":"Results Surf Interfaces"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100118_bib277","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/pharmaceutics13071042","article-title":"PLGA-based nanoparticles for neuroprotective drug delivery in neurodegenerative diseases","volume":"13","author":"Cunha","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmr.2026.100118_bib278","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112999","article-title":"Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): a current overview of active targeting in brain diseases","volume":"221","author":"Teixeira","year":"2023","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"52","key":"10.1016\/j.pharmr.2026.100118_bib279","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308150","article-title":"Transferrin receptor-targeted nonspherical microbubbles for blood\u2013brain barrier sonopermeation","volume":"35","author":"Dasgupta","year":"2023","journal-title":"Adv Mater"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib280","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijpharm.2011.06.030","article-title":"Curcumin and its nano-formulation: the kinetics of tissue distribution and blood\u2013brain barrier penetration","volume":"416","author":"Tsai","year":"2011","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib281","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/biom9020056","article-title":"Formulations of curcumin nanoparticles for brain diseases","volume":"9","author":"Del Prado-Audelo","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.pharmr.2026.100118_bib282","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejmech.2014.04.050","article-title":"Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease","volume":"80","author":"Mourtas","year":"2014","journal-title":"Eur J Med Chem"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100118_bib283","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3390\/biomedicines12071519","article-title":"Liposomes against Alzheimer\u2019s disease: current research and future prospects","volume":"12","author":"Constantinou","year":"2024","journal-title":"Biomedicines"},{"issue":"42","key":"10.1016\/j.pharmr.2026.100118_bib284","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1523\/JNEUROSCI.0284-14.2014","article-title":"Multifunctional liposomes reduce brain \u03b2-amyloid burden and ameliorate memory impairment in Alzheimer\u2019s disease mouse models","volume":"34","author":"Balducci","year":"2014","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100118_bib285","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijpharm.2011.05.062","article-title":"Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson\u2019s disease","volume":"415","author":"Hu","year":"2011","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib286","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41531-025-01081-1","article-title":"Revamping Parkinson\u2019s disease therapy using PLGA-based drug delivery systems","volume":"11","author":"Lababidi","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.pharmr.2026.100118_bib287","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.colsurfb.2017.01.031","article-title":"Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer\u2019s therapy","volume":"152","author":"Rassu","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib288","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40035-025-00503-7","article-title":"Targeted delivery of BACE1 siRNA for synergistic treatment of Alzheimer\u2019s disease","volume":"14","author":"Li","year":"2025","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.pharmr.2026.100118_bib289","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114968","article-title":"siRNA drug delivery across the blood\u2013brain barrier in Alzheimer\u2019s disease","volume":"199","author":"Imran Sajid","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmr.2026.100118_bib290","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fnagi.2019.00373","article-title":"Blood\u2013brain barrier and delivery of protein and gene therapeutics to brain","volume":"11","author":"Pardridge","year":"2020","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib291","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.coph.2006.06.001","article-title":"Molecular Trojan horses for blood\u2013brain barrier drug delivery","volume":"6","author":"Pardridge","year":"2006","journal-title":"Curr Opin Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100118_bib292","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood\u2013brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib293","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/bjp.2008.260","article-title":"Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2","volume":"155","author":"R\u00e9gina","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib294","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s11095-009-9964-5","article-title":"Uptake of ANG1005, a novel paclitaxel derivative, through the blood\u2013brain barrier into brain and experimental brain metastases of breast cancer","volume":"26","author":"Thomas","year":"2009","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib295","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10549-016-3972-z","article-title":"ANG1005 for breast cancer brain metastases: correlation between 18F-FLT-PET after first cycle and MRI in response assessment","volume":"160","author":"O\u2019Sullivan","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib296","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12951-022-01610-7","article-title":"Overcoming the blood\u2013brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches","volume":"20","author":"Mitusova","year":"2022","journal-title":"J Nanobiotechnology"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib297","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/1078-0432.CCR-19-3258","article-title":"ANG1005, a brain-penetrating peptide\u2013drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases","volume":"26","author":"Kumthekar","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib298","article-title":"Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma","volume":"6","author":"Dmello","year":"2024","journal-title":"Neurooncol Adv"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib299","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1695","article-title":"Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases","volume":"13","author":"Zhou","year":"2021","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100118_bib300","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.2174\/138920112800624364","article-title":"Ultrasound-induced blood\u2013brain barrier opening","volume":"13","author":"Konofagou","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib301","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/cn300191b","article-title":"Noninvasive and targeted drug delivery to the brain using focused ultrasound","volume":"4","author":"Burgess","year":"2013","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib302","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/17425247.2019.1567490","article-title":"Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood\u2013brain barrier permeability","volume":"16","author":"McMahon","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.pharmr.2026.100118_bib303","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115274","article-title":"Translating ultrasound-mediated drug delivery technologies for CNS applications","volume":"208","author":"Perolina","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib304","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.7863\/jum.2009.28.11.1501","article-title":"Focused ultrasound microbubble destruction-mediated changes in blood\u2013brain barrier permeability assessed by contrast-enhanced magnetic resonance imaging","volume":"28","author":"Wang","year":"2009","journal-title":"J Ultrasound Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib305","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMoa2308719","article-title":"Ultrasound blood\u2013brain barrier opening and aducanumab in Alzheimer\u2019s disease","volume":"390","author":"Rezai","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib306","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0271678X211046129","article-title":"A review of bioeffects induced by focused ultrasound combined with microbubbles on the neurovascular unit","volume":"42","author":"Chen","year":"2022","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2026.100118_bib307","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.778616","article-title":"Mathematical model of ultrasound attenuation with skull thickness for transcranial-focused ultrasound","volume":"15","author":"Guo","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmr.2026.100118_bib308","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115199","article-title":"From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research","volume":"206","author":"Bouakaz","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100118_bib309","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/pharmaceutics16101289","article-title":"Investigation of sonication parameters for large-volume focused ultrasound\u2013mediated blood\u2013brain barrier permeability enhancement using a clinical-prototype hemispherical phased array","volume":"16","author":"McMahon","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmr.2026.100118_bib310","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1341295","article-title":"Research progress in brain-targeted nasal drug delivery","volume":"15","author":"Huang","year":"2024","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib311","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cell.2025.01.017","article-title":"Engineered commensals for targeted nose-to-brain drug delivery","volume":"188","author":"Shen","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2026.100118_bib312","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2018.06.023","article-title":"Unintended effects of drug carriers: big issues of small particles","volume":"130","author":"Parhiz","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib313","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.tins.2022.03.003","article-title":"Neuroinflammation associated with ultrasound-mediated permeabilization of the blood\u2013brain barrier","volume":"45","author":"Jung","year":"2022","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib314","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tem.2024.04.021","article-title":"Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases","volume":"36","author":"Vazquez-Uribe","year":"2025","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib315","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00259-022-05997-1","article-title":"In vivo methods for imaging blood\u2013brain barrier function and dysfunction","volume":"50","author":"Harris","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib316","first-page":"529","article-title":"Advances in imaging techniques of the blood\u2013brain barrier and clinical application","volume":"20","author":"Cui","year":"2023","journal-title":"Curr Med Imaging"},{"key":"10.1016\/j.pharmr.2026.100118_bib317","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuroscience.2021.08.003","article-title":"Magnetic resonance imaging of blood\u2013brain barrier permeability in dementia","volume":"474","author":"Chagnot","year":"2021","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib318","doi-asserted-by":"crossref","first-page":"256","DOI":"10.13104\/imri.2022.26.4.256","article-title":"Dynamic contrast-enhanced MRI and its applications in various central nervous system diseases","volume":"26","author":"Kim","year":"2022","journal-title":"Investig Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib319","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/ijms24010251","article-title":"Circulating microRNAs and extracellular vesicle-derived microRNAs as predictors of functional recovery in ischemic stroke patients: a systematic review and meta-analysis","volume":"24","author":"Burlacu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib320","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70050","article-title":"Preclinical Alzheimer\u2019s disease shows alterations in circulating neuronal-derived extracellular vesicle microRNAs in a multiethnic cohort","volume":"21","author":"Reho","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib321","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ymthe.2018.02.032","article-title":"A blood-brain-barrier-penetrating anti-human transferrin receptor antibody fusion protein for neuronopathic mucopolysaccharidosis II","volume":"26","author":"Sonoda","year":"2018","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib322","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","article-title":"A phase 2\/3 trial of pabinafusp alfa, IDS fused with anti-human transferrin receptor antibody, targeting neurodegeneration in MPS-II","volume":"29","author":"Okuyama","year":"2021","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib323","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ymgme.2021.11.033","article-title":"Interim 49-week results of a phase 1\/2 study of intravenous DNL310 (brain-penetrant enzyme replacement therapy) in MPS II","volume":"135","author":"Bakardjiev","year":"2022","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib324","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2026.100118_bib484","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm6543","article-title":"A phase 2 study of thalidomide for the treatment of radiation-induced blood-brain barrier injury","volume":"15","author":"Cheng","year":"2023","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib325","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41598-018-36340-0","article-title":"Blood-brain barrier opening in primary brain tumors with non-invasive MR-guided focused ultrasound: a clinical safety and feasibility study","volume":"9","author":"Mainprize","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100118_bib326","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.541377","article-title":"Patterns of mitochondrial TSPO binding in cerebral small vessel disease: an in vivo PET study with neuropathological comparison","volume":"11","author":"Wright","year":"2020","journal-title":"Front Neurol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100118_bib327","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/bph.17458","article-title":"Novel drugs approved by the EMA, the FDA and the MHRA in 2024: a year in review","volume":"182","author":"Topouzis","year":"2025","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib328","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00418-021-01992-z","article-title":"Senescence and associated blood\u2013brain barrier alterations in vitro","volume":"156","author":"Salvador","year":"2021","journal-title":"Histochem Cell Biol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100118_bib329","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14270","article-title":"Blood\u2013brain barrier dysfunction in aging is mediated by brain endothelial senescence","volume":"23","author":"Novo","year":"2024","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib330","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/STROKEAHA.115.010835","article-title":"Vascular cell senescence contributes to blood\u2013brain barrier breakdown","volume":"47","author":"Yamazaki","year":"2016","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib331","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2045-824X-4-12","article-title":"Endothelial cell senescence is associated with disrupted cell\u2013cell junctions and increased monolayer permeability","volume":"4","author":"Krouwer","year":"2012","journal-title":"Vasc Cell"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib332","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210063","article-title":"Endothelial cell senescence effect on the blood\u2013brain barrier in stroke and cognitive impairment","volume":"103","author":"Real","year":"2024","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib333","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1007\/s11357-025-01561-5","article-title":"Transcriptomic profiling of senescence effects on blood\u2013brain barrier-related gene expression in brain capillary endothelial cells in a mouse model of paclitaxel-induced chemobrain","volume":"47","author":"Patai","year":"2025","journal-title":"GeroScience"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib337","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib334","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1159\/000522656","article-title":"Senolytics cocktail dasatinib and quercetin alleviate human umbilical vein endothelial cell senescence via the TRAF6\u2013MAPK\u2013NF-\u03baB axis in a YTHDF2-dependent manner","volume":"68","author":"Fan","year":"2022","journal-title":"Gerontology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib335","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1007\/s11357-024-01504-6","article-title":"The senolytic cocktail, dasatinib and quercetin, impacts the chromatin structure of both young and senescent vascular smooth muscle cells","volume":"47","author":"Gadecka","year":"2025","journal-title":"GeroScience"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib336","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2022.2103353","article-title":"Delay of endothelial cell senescence protects cerebral barrier against age-related dysfunction: role of senolytics and senomorphics","volume":"11","author":"Ya","year":"2023","journal-title":"Tissue Barriers"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib338","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/acel.12572","article-title":"Melatonin alleviates lipopolysaccharide-compromised integrity of blood\u2013brain barrier through activating AMP-activated protein kinase in old mice","volume":"16","author":"Wang","year":"2017","journal-title":"Aging Cell"},{"issue":"6156","key":"10.1016\/j.pharmr.2026.100118_bib339","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2026.100118_bib340","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2024.101158","article-title":"Melatonin and brain barriers: the protection conferred by melatonin to the blood\u2013brain barrier and blood\u2013cerebrospinal fluid barrier","volume":"75","author":"Mineiro","year":"2024","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib341","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.15354\/si.25.re1206","article-title":"Deep understanding of the role of sleep in brain cleansing","volume":"47","author":"Wang","year":"2025","journal-title":"Sci Insights"},{"key":"10.1016\/j.pharmr.2026.100118_bib342","article-title":"Senolytic therapy to modulate the progression of Alzheimer\u2019s disease (SToMP-AD): outcomes from the first clinical trial of senolytic therapy for Alzheimer\u2019s disease","author":"Gonzales","year":"2023","journal-title":"Res Sq [Preprint]"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib343","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/febs.16649","article-title":"Senescent cells in the brain and where to find them","volume":"290","author":"Rachmian","year":"2023","journal-title":"FEBS J"},{"key":"10.1016\/j.pharmr.2026.100118_bib344","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106711","article-title":"Senolytic therapy preserves blood\u2013brain barrier integrity and promotes microglia homeostasis in a tauopathy model","volume":"202","author":"Yao","year":"2024","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib345","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-024-00432-x","article-title":"Updates in Alzheimer\u2019s disease: from basic research to diagnosis and therapies","volume":"13","author":"Liu","year":"2024","journal-title":"Transl Neurodegener"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib346","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s44161-021-00014-4","article-title":"Blood\u2013brain barrier link to human cognitive impairment and Alzheimer\u2019s disease","volume":"1","author":"Barisano","year":"2022","journal-title":"Nat CardioVasc Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib347","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/s41467-024-46630-z","article-title":"A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer\u2019s disease","volume":"15","author":"Tsartsalis","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100118_bib348","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.695479","article-title":"Relationship between amyloid-\u03b2 deposition and blood\u2013brain barrier dysfunction in Alzheimer\u2019s disease","volume":"15","author":"Wang","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib349","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/156720508785908937","article-title":"Evidence for altered LRP\/RAGE expression in Alzheimer lesion pathogenesis","volume":"5","author":"Jeynes","year":"2008","journal-title":"Curr Alzheimer Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib350","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s11095-017-2267-3","article-title":"Endothelial LRP1\u2014A potential target for the treatment of Alzheimer\u2019s disease: theme: drug discovery, development and delivery in Alzheimer\u2019s disease guest editor: Davide Brambilla","volume":"34","author":"Storck","year":"2017","journal-title":"Pharm Res"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100118_bib351","article-title":"Blood\u2013brain barrier dysfunction in a 3D in vitro model of Alzheimer\u2019s disease","volume":"6","author":"Shin","year":"2019","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib352","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2020.02.074","article-title":"Disrupted blood\u2013brain barrier in 5\u00d7FAD mouse model of Alzheimer\u2019s disease can be mimicked and repaired in vitro with neural stem cell\u2013derived exosomes","volume":"525","author":"Liu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2026.100118_bib353","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1251195","article-title":"Accelerating the in vitro emulation of Alzheimer\u2019s disease\u2013associated phenotypes using a novel 3D blood\u2013brain barrier neurosphere co-culture model","volume":"11","author":"Ko","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib354","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12974-024-03024-8","article-title":"Modeling the neuroimmune system in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"21","author":"Balestri","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.pharmr.2026.100118_bib355","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122864","article-title":"Engineered 3D human neurovascular model of Alzheimer\u2019s disease to study vascular dysfunction","volume":"314","author":"Pavlou","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmr.2026.100118_bib356","first-page":"1","article-title":"Oxidative stress-mediated blood-brain barrier (BBB) disruption in neurological diseases","volume":"2020","author":"Song","year":"2020","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib357","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jshs.2016.10.004","article-title":"BACE1 inhibition as a therapeutic strategy for Alzheimer\u2019s disease","volume":"5","author":"Vassar","year":"2016","journal-title":"J Sport Health Sci"},{"key":"10.1016\/j.pharmr.2026.100118_bib358","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fchem.2018.00178","article-title":"Highlights in BACE1 inhibitors for Alzheimer\u2019s disease treatment","volume":"6","author":"Coimbra","year":"2018","journal-title":"Front Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib359","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1084\/jem.20181035","article-title":"3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice","volume":"216","author":"Lazic","year":"2019","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib360","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/biom11030358","article-title":"Activated protein C (APC) and 3K3A-APC-induced regression of choroidal neovascularization (CNV) is accompanied by vascular endothelial growth factor (VEGF) reduction","volume":"11","author":"Livnat","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.pharmr.2026.100118_bib361","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.870517","article-title":"Impact of anti\u2013amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer\u2019s disease: a focus on aducanumab and lecanemab","volume":"14","author":"Shi","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib362","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3233\/ADR-230025","article-title":"Antibody-mediated clearance of brain amyloid-\u03b2: mechanisms of action, effects of natural and monoclonal anti-A\u03b2 antibodies, and downstream effects","volume":"7","author":"Loeffler","year":"2023","journal-title":"J Alzheimers Dis Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib363","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2\u2013based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib364","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib365","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/ph13110394","article-title":"Treatment of Alzheimer\u2019s disease and blood\u2013brain barrier drug delivery","volume":"13","author":"Pardridge","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pharmr.2026.100118_bib366","article-title":"Utilization of nanotechnology to surmount the blood\u2013brain barrier in disorders of the central nervous system","volume":"31","author":"Luo","year":"2025","journal-title":"Mater Today Bio"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib367","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2422468","article-title":"Reverse engineering the gut\u2013brain axis and microbiome\u2013metabolomics for symbiotic\/pathogenic balance in neurodegenerative diseases","volume":"16","author":"Munir","year":"2024","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib368","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41598-024-84780-8","article-title":"Protection of Alzheimer\u2019s disease progression by a human-origin probiotics cocktail","volume":"15","author":"Prajapati","year":"2025","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib369","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/1073858420954811","article-title":"Cerebral amyloid angiopathy and blood\u2013brain barrier dysfunction","volume":"27","author":"Gireud-Goss","year":"2021","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5853\/jos.2023.01942","article-title":"Cerebral amyloid angiopathy: an undeniable small vessel disease","volume":"26","author":"Wang","year":"2024","journal-title":"J Stroke"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib371","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00018-024-05277-1","article-title":"Is CAA a perivascular brain clearance disease? A discussion of the evidence to date and outlook for future studies","volume":"81","author":"van Veluw","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib372","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bpa.12159","article-title":"Failure of perivascular drainage of \u03b2-amyloid in cerebral amyloid angiopathy","volume":"24","author":"Hawkes","year":"2014","journal-title":"Brain Pathol"},{"key":"10.1016\/j.pharmr.2026.100118_bib373","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120866","article-title":"Exploring cerebral amyloid angiopathy: insights into pathogenesis, diagnosis, and treatment","volume":"454","author":"Cozza","year":"2023","journal-title":"J Neurol Sci"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100118_bib374","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1042\/CS20170033","article-title":"Animal models of cerebral amyloid angiopathy","volume":"131","author":"J\u00e4kel","year":"2017","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100118_bib375","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.3390\/ijms21103435","article-title":"Understanding the pathophysiology of cerebral amyloid angiopathy","volume":"21","author":"Gatti","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib376","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.0808698106","article-title":"VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown","volume":"106","author":"Argaw","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7347","key":"10.1016\/j.pharmr.2026.100118_bib377","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib378","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2023.2292463","article-title":"Effect of bevacizumab on traumatic penumbra brain edema in rats at different time points","volume":"12","author":"Ai","year":"2024","journal-title":"Tissue Barriers"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib379","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-023-00388-4","article-title":"Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer\u2019s disease","volume":"13","author":"Zhang","year":"2024","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.pharmr.2026.100118_bib380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578395","article-title":"Targeting VEGF-mediated blood\u2013brain barrier disruption in advanced cerebral leukodystrophy","volume":"393","author":"Gupta","year":"2024","journal-title":"J Neuroimmunol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib381","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/NEN.0b013e3182724831","article-title":"Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T-cell responses","volume":"71","author":"MacMillan","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib382","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbalip.2017.09.008","article-title":"Regulatory effects of simvastatin and apoJ on APP processing and amyloid-\u03b2 clearance in blood-brain barrier endothelial cells","volume":"1863","author":"Zandl-Lang","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib383","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3233\/JAD-240212","article-title":"Approaches for increasing cerebral efflux of amyloid-\u03b2 in experimental systems","volume":"100","author":"Loeffler","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib384","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.pharmr.2026.100118_bib385","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.593026","article-title":"Blood\u2013brain barrier leakage is increased in Parkinson\u2019s disease","volume":"11","author":"Al-Bachari","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.pharmr.2026.100118_bib386","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.611761","article-title":"Alpha-synuclein in the regulation of brain endothelial and perivascular cells: gaps and future perspectives","volume":"12","author":"Bogale","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib387","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood\u2013brain barrier dysfunction in parkinsonian midbrain in vivo","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib388","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/AN20120066","article-title":"Neuroimmunological processes in Parkinson\u2019s disease and their relation to \u03b1-synuclein: microglia as the referee between neuronal processes and peripheral immunity","volume":"5","author":"Sanchez-Guajardo","year":"2013","journal-title":"ASN Neuro"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib389","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/ijms26062440","article-title":"Impact of peripheral inflammation on blood\u2013brain barrier dysfunction and its role in neurodegenerative diseases","volume":"26","author":"Beltran-Velasco","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib390","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.parkreldis.2012.12.002","article-title":"Changes in the blood\u2013brain barrier status closely correlate with the rate of disease progression in patients with multiple system atrophy: a longitudinal study","volume":"19","author":"Lee","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib391","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/neup.13021","article-title":"Blood\u2013brain barrier dysfunction in multiple system atrophy: a human postmortem study","volume":"45","author":"Gabdulkhaev","year":"2025","journal-title":"Neuropathology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib392","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12987-024-00575-z","article-title":"Blood\u2013brain barrier breakdown in dementia with Lewy bodies","volume":"21","author":"Gan","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib393","first-page":"694","article-title":"The future of Parkinson\u2019s disease research: a new paradigm of human-specific investigation is necessary\u2026 and possible","volume":"39","author":"Cassotta","year":"2022","journal-title":"ALTEX"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib394","article-title":"Improving treatment for Parkinson\u2019s disease: harnessing photothermal and phagocytosis-driven delivery of levodopa nanocarriers across the blood\u2013brain barrier","volume":"19","author":"Liang","year":"2024","journal-title":"Asian J Pharm Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib395","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/08977150151071035","article-title":"Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury","volume":"18","author":"Lau","year":"2001","journal-title":"J Neurotrauma"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib396","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/jnc.12041","article-title":"1\u03b1,25-Dihydroxyvitamin D3\u2013liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells","volume":"123","author":"Durk","year":"2012","journal-title":"J Neurochem"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100118_bib397","doi-asserted-by":"crossref","first-page":"8538","DOI":"10.3390\/ijms21228538","article-title":"Brain endothelial P-glycoprotein level is reduced in Parkinson\u2019s disease via a vitamin D receptor\u2013dependent pathway","volume":"21","author":"Kim","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib398","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbadis.2015.10.018","article-title":"Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke","volume":"1862","author":"Lopes Pinheiro","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib399","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/jnnp-2017-316011","article-title":"Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood\u2013brain barrier","volume":"89","author":"Spencer","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib400","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12974-020-01810-8","article-title":"Immuno-metabolic impact of multiple sclerosis patients\u2019 sera on endothelial cells of the blood\u2013brain barrier","volume":"17","author":"Sheikh","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib401","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/brain\/awv092","article-title":"Netrin 1 regulates blood\u2013brain barrier function and neuroinflammation","volume":"138","author":"Podjaski","year":"2015","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib402","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.3390\/ijms21124229","article-title":"Molecular effects of FDA-approved multiple sclerosis drugs on glial cells and neurons of the central nervous system","volume":"21","author":"De Kleijn","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib403","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12987-024-00599-5","article-title":"Role of the transcription factor NRF2 in maintaining the integrity of the blood\u2013brain barrier","volume":"21","author":"Cazalla","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib404","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s13311-017-0565-4","article-title":"Sphingosine 1-phosphate receptor modulators for the treatment of multiple sclerosis","volume":"14","author":"Chaudhry","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100118_bib405","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-022-00927-z","article-title":"The two sides of siponimod: evidence for brain and immune mechanisms in multiple sclerosis","volume":"36","author":"Cohan","year":"2022","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib406","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/14656566.2023.2178898","article-title":"An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis","volume":"24","author":"Dumitrescu","year":"2023","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmr.2026.100118_bib407","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103264","article-title":"Acting centrally or peripherally: a renewed interest in the central nervous system penetration of disease-modifying drugs in multiple sclerosis","volume":"56","author":"Correale","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib408","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics\u20132021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2026.100118_bib409","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.605398","article-title":"Blood\u2013brain barrier damage in ischemic stroke and its regulation by endothelial mechanotransduction","volume":"11","author":"Nian","year":"2020","journal-title":"Front Physiol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib410","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4103\/1673-5374.239445","article-title":"Hyperoside protects the blood\u2013brain barrier from neurotoxicity of amyloid beta 1\u201342","volume":"13","author":"Liu","year":"2018","journal-title":"Neural Regen Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib411","doi-asserted-by":"crossref","first-page":"924","DOI":"10.14336\/AD.2017.1126","article-title":"Mitochondria in ischemic stroke: new insight and implications","volume":"9","author":"Liu","year":"2018","journal-title":"Aging Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib412","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41392-022-01064-1","article-title":"Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.pharmr.2026.100118_bib413","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1513084","article-title":"Chaperones vs. oxidative stress in the pathobiology of ischemic stroke","volume":"17","author":"Soldatov","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.pharmr.2026.100118_bib414","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1286351","article-title":"Emerging diagnostic markers and therapeutic targets in post-stroke hemorrhagic transformation and brain edema","volume":"16","author":"Yao","year":"2023","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib415","doi-asserted-by":"crossref","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","article-title":"Neuroinflammatory mechanisms of blood\u2013brain barrier damage in ischemic stroke","volume":"316","author":"Yang","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib416","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","article-title":"Neuroinflammation: friend and foe for ischemic stroke","volume":"16","author":"Jayaraj","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100118_bib417","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.3390\/ijms23137140","article-title":"Promising strategies for the development of advanced in vitro models with high predictive power in ischaemic stroke research","volume":"23","author":"Van Breedam","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100118_bib418","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114942","article-title":"In vitro modelling of the neurovascular unit for ischemic stroke research: emphasis on human cell applications and 3D model design","volume":"381","author":"Pang","year":"2024","journal-title":"Exp Neurol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib419","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/jcbfm.2011.127","article-title":"Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence","volume":"31","author":"Vivien","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100118_bib420","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3174\/ajnr.A1774","article-title":"Recombinant tissue plasminogen activator increases blood\u2013brain barrier disruption in acute ischemic stroke: an MR imaging permeability study","volume":"30","author":"Kassner","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib421","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12987-021-00280-1","article-title":"Adjunctive cytoprotective therapies in acute ischemic stroke: a systematic review","volume":"18","author":"Mulder","year":"2021","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.pharmr.2026.100118_bib422","article-title":"Advances in the research of nano delivery systems in ischemic stroke","volume":"10","author":"Li","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.pharmr.2026.100118_bib423","article-title":"Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies","volume":"335","author":"Paul","year":"2020","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmr.2026.100118_bib424","series-title":"Translational Research in Traumatic Brain Injury","first-page":"108","article-title":"Blood\u2013brain barrier pathophysiology following traumatic brain injury","author":"Price","year":"2016"},{"key":"10.1016\/j.pharmr.2026.100118_bib425","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3389\/fphys.2020.01030","article-title":"Blood\u2013brain barrier dysfunction in mild traumatic brain injury: evidence from preclinical murine models","volume":"11","author":"Wu","year":"2020","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib426","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12975-011-0125-x","article-title":"Blood\u2013brain barrier pathophysiology in traumatic brain injury","volume":"2","author":"Chodobski","year":"2011","journal-title":"Transl Stroke Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib427","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1038\/s41598-021-84730-8","article-title":"Blast-induced temporal alterations in blood\u2013brain barrier properties in a rodent model","volume":"11","author":"Kawoos","year":"2021","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100118_bib428","first-page":"1470","article-title":"Cerebral vascular disturbances following traumatic brain injury: pathophysiology, diagnosis, and therapeutic perspectives-a narrative review","volume":"15","author":"Serban","year":"2025","journal-title":"Life (Basel)"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib429","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00401-018-1824-0","article-title":"Mechanical disruption of the blood\u2013brain barrier following experimental concussion","volume":"135","author":"Johnson","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"B","key":"10.1016\/j.pharmr.2026.100118_bib430","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuropharm.2018.08.004","article-title":"Pathophysiology and treatment of cerebral edema in traumatic brain injury","volume":"145","author":"Jha","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2026.100118_bib431","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.740939","article-title":"Traumatic brain injury: mechanisms of glial response","volume":"12","author":"Mira","year":"2021","journal-title":"Front Physiol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib432","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/glia.24609","article-title":"Endothelin-1 increases Na+-K+-2Cl\u2212 cotransporter-1 expression in cultured astrocytes and in traumatic brain injury model: an involvement of HIF1\u03b1 activation","volume":"72","author":"Koyama","year":"2024","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib433","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jnr.24331","article-title":"Neuroinflammation and blood\u2013brain barrier disruption following traumatic brain injury: pathophysiology and potential therapeutic targets","volume":"98","author":"Sulhan","year":"2018","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib434","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1545968315586465","article-title":"Brain-derived neurotrophic factor (BDNF) in traumatic brain injury-related mortality: interrelationships between genetics and acute systemic and central nervous system BDNF profiles","volume":"30","author":"Failla","year":"2016","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.pharmr.2026.100118_bib435","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fnins.2019.00790","article-title":"Therapeutic potential of neurotrophins for repair after brain injury: a helping hand from biomaterials","volume":"13","author":"Houlton","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmr.2026.100118_bib436","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib437","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1093\/neuonc\/noab133","article-title":"Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma","volume":"23","author":"Marin","year":"2021","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib438","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","article-title":"Repeated blood\u2013brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial","volume":"24","author":"Sonabend","year":"2023","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib439","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11060-019-03204-0","article-title":"Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma","volume":"144","author":"Dr\u00e9an","year":"2019","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib440","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/cncr.10397","article-title":"Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing: a surrogate marker of brain penetration","volume":"94","author":"Kellie","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib441","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/cancers11060824","article-title":"Improving the brain delivery of chemotherapeutic drugs in childhood brain tumors","volume":"11","author":"Triarico","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"37","key":"10.1016\/j.pharmr.2026.100118_bib442","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103280118","article-title":"Localized blood\u2013brain barrier opening in infiltrating gliomas with MRI-guided acoustic emissions\u2013controlled focused ultrasound","volume":"118","author":"Anastasiadis","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib443","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijrobp.2020.12.019","article-title":"Focused ultrasound\u2013mediated blood\u2013brain barrier opening increases delivery and efficacy of etoposide for glioblastoma treatment","volume":"110","author":"Wei","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib444","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3171\/2019.10.JNS192206","article-title":"Safety and feasibility of multiple blood\u2013brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy","volume":"134","author":"Park","year":"2021","journal-title":"J Neurosurg"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib445","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1158\/1541-7786.MCR-19-0995","article-title":"Adenosine A2a receptor activation enhances blood\u2013tumor barrier permeability in a rodent glioma model","volume":"19","author":"V\u00e9zina","year":"2021","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib446","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12987-017-0088-8","article-title":"The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma","volume":"15","author":"Jackson","year":"2018","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib447","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood\u2013brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmr.2026.100118_bib448","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.902261","article-title":"Emerging cellular themes in leukodystrophies","volume":"10","author":"Nowacki","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib449","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12987-022-00316-0","article-title":"The neurovascular unit in leukodystrophies: towards solving the puzzle","volume":"19","author":"Zarekiani","year":"2022","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100118_bib450","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","article-title":"Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms","volume":"134","author":"van der Knaap","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100118_bib451","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012889","article-title":"Attenuated CSF-1R signalling drives cerebrovascular pathology","volume":"13","author":"Delaney","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100118_bib452","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1002\/mds.28734","article-title":"Treatment of CSF1R-related leukoencephalopathy: breaking new ground","volume":"36","author":"Tipton","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharmr.2026.100118_bib453","article-title":"Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: review of clinical manifestations as foundations for therapeutic development","volume":"12","author":"Papapetropoulos","year":"2021","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib454","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40478-021-01206-6","article-title":"Pathology of the neurovascular unit in leukodystrophies","volume":"9","author":"Zarekiani","year":"2021","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib455","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/brain\/awv250","article-title":"Brain endothelial dysfunction in cerebral adrenoleukodystrophy","volume":"138","author":"Musolino","year":"2015","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100118_bib456","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/brain\/awy127","article-title":"Impaired plasticity of macrophages in X-linked adrenoleukodystrophy","volume":"141","author":"Weinhofer","year":"2018","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100118_bib457","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bpa.12181","article-title":"CADASIL and CARASIL","volume":"24","author":"Tikka","year":"2014","journal-title":"Brain Pathol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100118_bib458","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1161\/STR.0000000000000444","article-title":"Management of inherited CNS small vessel diseases: the CADASIL example: a scientific statement from the American Heart Association","volume":"54","author":"Meschia","year":"2023","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib459","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12987-023-00428-1","article-title":"Genetic disorders and genetic manipulation at the blood\u2013brain barriers","volume":"20","author":"Keep","year":"2023","journal-title":"Fluids Barriers CNS"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib460","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41431-020-0669-x","article-title":"Biallelic MFSD2A variants associated with congenital microcephaly, developmental delay, and recognizable neuroimaging features","volume":"28","author":"Scala","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100118_bib461","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1093\/brain\/awac215","article-title":"Recurrent de novo mutations in CLDN5 induce an anion-selective blood\u2013brain barrier and alternating hemiplegia","volume":"145","author":"Hashimoto","year":"2022","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib462","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/hmg\/ddp584","article-title":"Col4a1 mutation in mice causes defects in vascular function and low blood pressure associated with reduced red blood cell volume","volume":"19","author":"van Agtmael","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib463","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajhg.2011.11.022","article-title":"COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke","volume":"90","author":"Jeanne","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100118_bib464","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/bpa.12158","article-title":"PDGF, pericytes and the pathogenesis of idiopathic basal ganglia calcification (IBGC)","volume":"24","author":"Betsholtz","year":"2014","journal-title":"Brain Pathol"},{"issue":"7806","key":"10.1016\/j.pharmr.2026.100118_bib465","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib466","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/STROKEAHA.119.024151","article-title":"Genetics of cerebral small vessel disease","volume":"51","author":"Marini","year":"2019","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib467","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/mp.2017.156","article-title":"Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia","volume":"23","author":"Greene","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100118_bib468","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.eurpsy.2004.06.007","article-title":"The CLDN5 locus may be involved in the vulnerability to schizophrenia","volume":"19","author":"Sun","year":"2004","journal-title":"Eur Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib469","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12987-021-00250-7","article-title":"Epigenetics in blood\u2013brain barrier disruption","volume":"18","author":"Ihezie","year":"2021","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.pharmr.2026.100118_bib470","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86978","article-title":"Key epigenetic and signaling factors in the formation and maintenance of the blood-brain barrier","volume":"12","author":"Sadanandan","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.pharmr.2026.100118_bib471","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2020.08.006","article-title":"A subtype of cerebrovascular pericytes is associated with blood-brain barrier disruption that develops during normal aging and simian immunodeficiency virus infection","volume":"96","author":"Bohannon","year":"2020","journal-title":"Neurobiol Aging"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100118_bib472","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111189","article-title":"The blood-brain barrier-a metabolic ecosystem","volume":"41","author":"Castro","year":"2022","journal-title":"EMBO J"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100118_bib473","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417146","article-title":"Astrocyte involvement in blood-brain barrier function: a critical update highlighting novel, complex, neurovascular interactions","volume":"24","author":"Manu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib474","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12987-024-00557-1","article-title":"Cellular and molecular mechanisms of the blood-brain barrier dysfunction in neurodegenerative diseases","volume":"21","author":"Chen","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100118_bib475","doi-asserted-by":"crossref","first-page":"H1702","DOI":"10.1152\/ajpheart.00774.2015","article-title":"Differences in the molecular structure of the blood-brain barrier in the cerebral cortex and white matter: an in silico, in vitro, and ex vivo study","volume":"310","author":"Ny\u00fal-T\u00f3th","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmr.2026.100118_bib476","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.948959","article-title":"MicroRNAs in extracellular vesicles: sorting mechanisms, diagnostic value, isolation, and detection technology","volume":"10","author":"Xu","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.pharmr.2026.100118_bib477","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1132077","article-title":"Imaging blood-brain barrier dysfunction: a state-of-the-art review from a clinical perspective","volume":"15","author":"Moyaert","year":"2023","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100118_bib478","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1007\/s12035-025-04825-5","article-title":"Exosomes as biomarkers and therapeutic agents in neurodegenerative diseases: current insights and future directions","volume":"62","author":"Dehghani","year":"2025","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib479","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.pharmr.2026.100118_bib480","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/bs.acr.2024.06.003","article-title":"Precision medicine focus on the central nervous system: non-invasive therapeutic agent delivery with focused ultrasound and microbubbles","volume":"164","author":"Mannangatti","year":"2024","journal-title":"Adv Cancer Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib481","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-08387-7","article-title":"Blood\u2013brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins","volume":"12","author":"Hernandez","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100118_bib482","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2022.08.051","article-title":"Recent advances in drug delivery and targeting to the brain","volume":"350","author":"Sethi","year":"2022","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100118_bib483","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:21:52Z","timestamp":1774434112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":484,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0031699726000062"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100118","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological modulation of the blood-brain barrier: Mechanisms, therapeutic strategies, and emerging technologies","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100118"}}